Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1991 Oct 1;145(7):793–804.

Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease?

D R McLachlan 1, T P Kruck 1, W J Lukiw 1, S S Krishnan 1
PMCID: PMC1335899  PMID: 1822096

Abstract

Although the cause of Alzheimer's disease (AD) remains unknown there is mounting evidence that implicates aluminum as a toxic environmental factor of considerable importance. Four independent lines of evidence--laboratory studies of the effects of intracerebral aluminum on the cognitive and memory performance of animals, biochemical studies, epidemiologic studies and the slowing of the progress of the disease with the use of an agent that removes aluminum from the body--now support the concept that aluminum is one of the pathogenic factors in AD. The evidence warrants serious consideration of reducing human exposure to aluminum. We hypothesize that a public health effort to restrict human ingestion of aluminum would reduce the incidence of this common chronic illness in the elderly.

Full text

PDF
793

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altmann P., Al-Salihi F., Butter K., Cutler P., Blair J., Leeming R., Cunningham J., Marsh F. Serum aluminum levels and erythrocyte dihydropteridine reductase activity in patients on hemodialysis. N Engl J Med. 1987 Jul 9;317(2):80–84. doi: 10.1056/NEJM198707093170204. [DOI] [PubMed] [Google Scholar]
  2. Altmann P., Dhanesha U., Hamon C., Cunningham J., Blair J., Marsh F. Disturbance of cerebral function by aluminium in haemodialysis patients without overt aluminium toxicity. Lancet. 1989 Jul 1;2(8653):7–12. doi: 10.1016/s0140-6736(89)90254-7. [DOI] [PubMed] [Google Scholar]
  3. Banks W. A., Kastin A. J. Aluminium increases permeability of the blood-brain barrier to labelled DSIP and beta-endorphin: possible implications for senile and dialysis dementia. Lancet. 1983 Nov 26;2(8361):1227–1229. doi: 10.1016/s0140-6736(83)91273-4. [DOI] [PubMed] [Google Scholar]
  4. Banks W. A., Kastin A. J., Fasold M. B. Differential effect of aluminum on the blood-brain barrier transport of peptides, technetium and albumin. J Pharmacol Exp Ther. 1988 Feb;244(2):579–585. [PubMed] [Google Scholar]
  5. Bishop N. J., Robinson M. J., Lendon M., Hewitt C. D., Day J. P., O'Hara M. Increased concentration of aluminium in the brain of a parenterally fed preterm infant. Arch Dis Child. 1989 Sep;64(9):1316–1317. doi: 10.1136/adc.64.9.1316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bizzi A., Crane R. C., Autilio-Gambetti L., Gambetti P. Aluminum effect on slow axonal transport: a novel impairment of neurofilament transport. J Neurosci. 1984 Mar;4(3):722–731. doi: 10.1523/JNEUROSCI.04-03-00722.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Candy J. M., Oakley A. E., Klinowski J., Carpenter T. A., Perry R. H., Atack J. R., Perry E. K., Blessed G., Fairbairn A., Edwardson J. A. Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet. 1986 Feb 15;1(8477):354–357. doi: 10.1016/s0140-6736(86)92319-6. [DOI] [PubMed] [Google Scholar]
  8. Clark A. W., Krekoski C. A., Parhad I. M., Liston D., Julien J. P., Hoar D. I. Altered expression of genes for amyloid and cytoskeletal proteins in Alzheimer cortex. Ann Neurol. 1989 Apr;25(4):331–339. doi: 10.1002/ana.410250404. [DOI] [PubMed] [Google Scholar]
  9. Cochran M., Elliott D. C., Brennan P., Chawtur V. Inhibition of protein kinase C activation by low concentrations of aluminium. Clin Chim Acta. 1990 Dec 24;194(2-3):167–172. doi: 10.1016/0009-8981(90)90131-b. [DOI] [PubMed] [Google Scholar]
  10. Crapper D. R., Dalton A. J. Alterations in short-term retention, conditioned avoidance response acquisition and motivation following aluminum induced neurofibrillary degeneration. Physiol Behav. 1973 May;10(5):925–933. doi: 10.1016/0031-9384(73)90063-2. [DOI] [PubMed] [Google Scholar]
  11. Crapper D. R. Experimental neurofibrillary degeneration and altered electrical activity. Electroencephalogr Clin Neurophysiol. 1973 Dec;35(6):575–588. doi: 10.1016/0013-4694(73)90211-3. [DOI] [PubMed] [Google Scholar]
  12. Crapper D. R., Krishnan S. S., Quittkat S. Aluminium, neurofibrillary degeneration and Alzheimer's disease. Brain. 1976 Mar;99(1):67–80. doi: 10.1093/brain/99.1.67. [DOI] [PubMed] [Google Scholar]
  13. Crapper D. R., Quittkat S., Krishnan S. S., Dalton A. J., De Boni U. Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy. Acta Neuropathol. 1980;50(1):19–24. doi: 10.1007/BF00688530. [DOI] [PubMed] [Google Scholar]
  14. Crapper D. R., Tomko G. J. Neuronal correlates of an encephalopathy associated with aluminum neurofibrillary degeneration. Brain Res. 1975 Oct 31;97(2):253–264. doi: 10.1016/0006-8993(75)90448-5. [DOI] [PubMed] [Google Scholar]
  15. Dahl D., Bignami A. Immunochemical cross-reactivity of normal neurofibrils and aluminum-induced neurofibrillary tangles. Immunofluorescence study with antineurofilament serum. Exp Neurol. 1978 Jan 1;58(1):74–80. doi: 10.1016/0014-4886(78)90122-x. [DOI] [PubMed] [Google Scholar]
  16. Deleers M. Cationic atmosphere and cation competition binding at negatively charged membranes: pathological implications of aluminum. Res Commun Chem Pathol Pharmacol. 1985 Aug;49(2):277–294. [PubMed] [Google Scholar]
  17. Deleers M., Servais J. P., Wülfert E. Micromolar concentrations of Al3+ induce phase separation, aggregation and dye release in phosphatidylserine-containing lipid vesicles. Biochim Biophys Acta. 1985 Mar 14;813(2):195–200. doi: 10.1016/0005-2736(85)90233-0. [DOI] [PubMed] [Google Scholar]
  18. Edwardson J. A., Candy J. M. Aluminium and the pathogenesis of senile plaques in Alzheimer's disease, Down's syndrome and chronic renal dialysis. Ann Med. 1989;21(2):95–97. doi: 10.3109/07853898909149192. [DOI] [PubMed] [Google Scholar]
  19. Farnell B. J., Crapper McLachlan D. R., Baimbridge K., De Boni U., Wong L., Wood P. L. Calcium metabolism in aluminum encephalopathy. Exp Neurol. 1985 Apr;88(1):68–83. doi: 10.1016/0014-4886(85)90114-1. [DOI] [PubMed] [Google Scholar]
  20. Farrar G., Altmann P., Welch S., Wychrij O., Ghose B., Lejeune J., Corbett J., Prasher V., Blair J. A. Defective gallium-transferrin binding in Alzheimer disease and Down syndrome: possible mechanism for accumulation of aluminium in brain. Lancet. 1990 Mar 31;335(8692):747–750. doi: 10.1016/0140-6736(90)90868-6. [DOI] [PubMed] [Google Scholar]
  21. Fleming J., Joshi J. G. Ferritin: isolation of aluminum-ferritin complex from brain. Proc Natl Acad Sci U S A. 1987 Nov;84(22):7866–7870. doi: 10.1073/pnas.84.22.7866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Fleming J., Joshi J. G. Ferritin: isolation of aluminum-ferritin complex from brain. Proc Natl Acad Sci U S A. 1987 Nov;84(22):7866–7870. doi: 10.1073/pnas.84.22.7866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Goate A., Chartier-Harlin M. C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991 Feb 21;349(6311):704–706. doi: 10.1038/349704a0. [DOI] [PubMed] [Google Scholar]
  24. Graves A. B., White E., Koepsell T. D., Reifler B. V., van Belle G., Larson E. B. The association between aluminum-containing products and Alzheimer's disease. J Clin Epidemiol. 1990;43(1):35–44. doi: 10.1016/0895-4356(90)90053-r. [DOI] [PubMed] [Google Scholar]
  25. Gruca S., Wisniewski H. M. Cytochemical study on the effect of aluminum on neuronal Golgi apparatus and lysosomes. Acta Neuropathol. 1984;63(4):287–295. doi: 10.1007/BF00687335. [DOI] [PubMed] [Google Scholar]
  26. Guillaume J. C., Saiag P., Wechsler J., Lescs M. C., Roujeau J. C. Vaccinia from recombinant virus expressing HIV genes. Lancet. 1991 Apr 27;337(8748):1034–1035. doi: 10.1016/0140-6736(91)92689-y. [DOI] [PubMed] [Google Scholar]
  27. Gutteridge J. M., Quinlan G. J., Clark I., Halliwell B. Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts. Biochim Biophys Acta. 1985 Jul 31;835(3):441–447. doi: 10.1016/0005-2760(85)90113-4. [DOI] [PubMed] [Google Scholar]
  28. Guy S. P., Jones D., Mann D. M., Itzhaki R. F. Human neuroblastoma cells treated with aluminium express an epitope associated with Alzheimer's disease neurofibrillary tangles. Neurosci Lett. 1991 Jan 2;121(1-2):166–168. doi: 10.1016/0304-3940(91)90676-k. [DOI] [PubMed] [Google Scholar]
  29. Hava M., Hurwitz A. The relaxing effect of aluminum and lanthanum on rat and human gastric smooth muscle in vitro. Eur J Pharmacol. 1973 May;22(2):156–161. doi: 10.1016/0014-2999(73)90006-x. [DOI] [PubMed] [Google Scholar]
  30. Hazlett T. L., Higashijima T., Jameson D. M. Examination of elongation factor Tu for aluminum fluoride binding sites using fluorescence and 19F-NMR methodologies. FEBS Lett. 1991 Jan 28;278(2):225–228. doi: 10.1016/0014-5793(91)80122-j. [DOI] [PubMed] [Google Scholar]
  31. Hetnarski B., Wisniewski H. M., Iqbal K., Dziedzic J. D., Lajtha A. Central cholinergic activity in aluminum-induced neurofibrillary degeneration. Ann Neurol. 1980 May;7(5):489–490. doi: 10.1002/ana.410070517. [DOI] [PubMed] [Google Scholar]
  32. Hunter D., Ross D. S. Evidence for a phytotoxic hydroxy-aluminum polymer in organic soil horizons. Science. 1991 Mar 1;251(4997):1056–1058. doi: 10.1126/science.251.4997.1056. [DOI] [PubMed] [Google Scholar]
  33. Johnson G. V., Jope R. S. Aluminum alters cyclic AMP and cyclic GMP levels but not presynaptic cholinergic markers in rat brain in vivo. Brain Res. 1987 Feb 10;403(1):1–6. doi: 10.1016/0006-8993(87)90115-6. [DOI] [PubMed] [Google Scholar]
  34. KLATZO I., WISNIEWSKI H., STREICHER E. EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION. I. LIGHT MICROSCOPIC OBSERVATIONS. J Neuropathol Exp Neurol. 1965 Apr;24:187–199. doi: 10.1097/00005072-196504000-00002. [DOI] [PubMed] [Google Scholar]
  35. Karlik S. J., Eichhorn G. L., Lewis P. N., Crapper D. R. Interaction of aluminum species with deoxyribonucleic acid. Biochemistry. 1980 Dec 23;19(26):5991–5998. doi: 10.1021/bi00567a008. [DOI] [PubMed] [Google Scholar]
  36. Katsetos C. D., Savory J., Herman M. M., Carpenter R. M., Frankfurter A., Hewitt C. D., Wills M. R. Neuronal cytoskeletal lesions induced in the CNS by intraventricular and intravenous aluminium maltol in rabbits. Neuropathol Appl Neurobiol. 1990 Dec;16(6):511–528. doi: 10.1111/j.1365-2990.1990.tb01290.x. [DOI] [PubMed] [Google Scholar]
  37. Koenig M. L., Jope R. S. Aluminum inhibits the fast phase of voltage-dependent calcium influx into synaptosomes. J Neurochem. 1987 Jul;49(1):316–320. doi: 10.1111/j.1471-4159.1987.tb03432.x. [DOI] [PubMed] [Google Scholar]
  38. Kosik K. S., McCluskey A. H., Walsh F. X., Selkoe D. J. Axonal transport of cytoskeletal proteins in aluminum toxicity. Aluminum toxicity and axonal transport. Neurochem Pathol. 1985 Summer;3(2):99–108. doi: 10.1007/BF02834283. [DOI] [PubMed] [Google Scholar]
  39. Krishnan S. S., McLachlan D. R., Krishnan B., Fenton S. S., Harrison J. E. Aluminum toxicity to the brain. Sci Total Environ. 1988 Apr;71(1):59–64. doi: 10.1016/0048-9697(88)90299-9. [DOI] [PubMed] [Google Scholar]
  40. Lai J. C., Blass J. P. Inhibition of brain glycolysis by aluminum. J Neurochem. 1984 Feb;42(2):438–446. doi: 10.1111/j.1471-4159.1984.tb02697.x. [DOI] [PubMed] [Google Scholar]
  41. Lai J. C., Guest J. F., Leung T. K., Lim L., Davison A. N. The effects of cadmium, manganese and aluminium on sodium-potassium-activated and magnesium-activated adenosine triphosphatase activity and choline uptake in rat brain synaptosomes. Biochem Pharmacol. 1980 Feb;29(2):141–146. doi: 10.1016/0006-2952(80)90321-4. [DOI] [PubMed] [Google Scholar]
  42. Lai J. C., Lim L., Davison A. N. Effects of Cd2+, Mn2+, and Al3+ on rat brain synaptosomal uptake of noradrenaline and serotonin. J Inorg Biochem. 1982 Nov;17(3):215–225. doi: 10.1016/s0162-0134(00)80100-2. [DOI] [PubMed] [Google Scholar]
  43. Lee V. M., Balin B. J., Otvos L., Jr, Trojanowski J. Q. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science. 1991 Feb 8;251(4994):675–678. doi: 10.1126/science.1899488. [DOI] [PubMed] [Google Scholar]
  44. Lipman J. J., Colowick S. P., Lawrence P. L., Abumrad N. N. Aluminum induced encephalopathy in the rat. Life Sci. 1988;42(8):863–875. doi: 10.1016/0024-3205(88)90385-2. [DOI] [PubMed] [Google Scholar]
  45. Liwnicz B. H., Kristensson K., Wiśniewski H. M., Shelanski M. L., Terry R. D. Observations on axoplasmic transport in rabbits with aluminum-induced neurofibrillary tangles. Brain Res. 1974 Nov 22;80(3):413–420. doi: 10.1016/0006-8993(74)91026-9. [DOI] [PubMed] [Google Scholar]
  46. Lukiw W. J., Kruck T. P., McLachlan D. R. Alterations in human linker histone-DNA binding in the presence of aluminum salts in vitro and in Alzheimer's disease. Neurotoxicology. 1987 Summer;8(2):291–301. [PubMed] [Google Scholar]
  47. MCLAUGHLIN A. I., KAZANTZIS G., KING E., TEARED, PORTER R. J., OWEN R. Pulmonary fibrosis and encephalopathy associated with the inhalation of aluminium dust. Br J Ind Med. 1962 Oct;19:253–263. doi: 10.1136/oem.19.4.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Macdonald T. L., Humphreys W. G., Martin R. B. Promotion of tubulin assembly by aluminum ion in vitro. Science. 1987 Apr 10;236(4798):183–186. doi: 10.1126/science.3105058. [DOI] [PubMed] [Google Scholar]
  49. Macdonald T. L., Martin R. B. Aluminum ion in biological systems. Trends Biochem Sci. 1988 Jan;13(1):15–19. doi: 10.1016/0968-0004(88)90012-6. [DOI] [PubMed] [Google Scholar]
  50. Mansour J. M., Ehrlich A., Mansour T. E. The dual effects of aluminum as activator and inhibitor of adenylate cyclase in the liver fluke Fasciola hepatica. Biochem Biophys Res Commun. 1983 May 16;112(3):911–918. doi: 10.1016/0006-291x(83)91704-7. [DOI] [PubMed] [Google Scholar]
  51. Marquis J. K. Aluminum inhibition of human serum cholinesterase. Bull Environ Contam Toxicol. 1983 Aug;31(2):164–169. doi: 10.1007/BF01607888. [DOI] [PubMed] [Google Scholar]
  52. Marquis J. K. Aluminum neurotoxicity: an experimental perspective. Bull Environ Contam Toxicol. 1982 Jul;29(1):43–49. doi: 10.1007/BF01606087. [DOI] [PubMed] [Google Scholar]
  53. Marquis J. K., Lerrick A. J. Noncompetitive inhibition by aluminum, scandium and yttrium of acetylcholinesterase from Electrophorus electricus. Biochem Pharmacol. 1982 Apr 1;31(7):1437–1440. doi: 10.1016/0006-2952(82)90040-5. [DOI] [PubMed] [Google Scholar]
  54. Martyn C. N., Barker D. J., Osmond C., Harris E. C., Edwardson J. A., Lacey R. F. Geographical relation between Alzheimer's disease and aluminum in drinking water. Lancet. 1989 Jan 14;1(8629):59–62. [PubMed] [Google Scholar]
  55. McGeer P. L., McGeer E., Rogers J., Sibley J. Anti-inflammatory drugs and Alzheimer disease. Lancet. 1990 Apr 28;335(8696):1037–1037. doi: 10.1016/0140-6736(90)91101-f. [DOI] [PubMed] [Google Scholar]
  56. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
  57. McLachlan D. R., Dam T. V., Farnell B. J., Lewis P. N. Aluminum inhibition of ADP-ribosylation in vivo and in vitro. Neurobehav Toxicol Teratol. 1983 Nov-Dec;5(6):645–647. [PubMed] [Google Scholar]
  58. McLachlan D. R., Lukiw W. J., Kruck T. P. New evidence for an active role of aluminum in Alzheimer's disease. Can J Neurol Sci. 1989 Nov;16(4 Suppl):490–497. doi: 10.1017/s0317167100029826. [DOI] [PubMed] [Google Scholar]
  59. McLachlan D. R., Lukiw W. J., Wong L., Bergeron C., Bech-Hansen N. T. Selective messenger RNA reduction in Alzheimer's disease. Brain Res. 1988 Jun;427(3):255–261. doi: 10.1016/0169-328x(88)90048-4. [DOI] [PubMed] [Google Scholar]
  60. Miller C. A., Levine E. M. Effects of aluminum salts on cultured neuroblastoma cells. J Neurochem. 1974 May;22(5):751–758. doi: 10.1111/j.1471-4159.1974.tb04290.x. [DOI] [PubMed] [Google Scholar]
  61. Morandi A., Los B., Osofsky L., Autilio-Gambetti L., Gambetti P. Ubiquitin and heat shock proteins in cultured nervous tissue after different stress conditions. Prog Clin Biol Res. 1989;317:819–827. [PubMed] [Google Scholar]
  62. Muller G., Bernuzzi V., Desor D., Hutin M. F., Burnel D., Lehr P. R. Developmental alterations in offspring of female rats orally intoxicated by aluminum lactate at different gestation periods. Teratology. 1990 Sep;42(3):253–261. doi: 10.1002/tera.1420420309. [DOI] [PubMed] [Google Scholar]
  63. Muma N. A., Troncoso J. C., Hoffman P. N., Koo E. H., Price D. L. Aluminum neurotoxicity: altered expression of cytoskeletal genes. Brain Res. 1988 Apr;427(2):115–121. doi: 10.1016/0169-328x(88)90056-3. [DOI] [PubMed] [Google Scholar]
  64. Munoz-Garcia D., Pendlebury W. W., Kessler J. B., Perl D. P. An immunocytochemical comparison of cytoskeletal proteins in aluminum-induced and Alzheimer-type neurofibrillary tangles. Acta Neuropathol. 1986;70(3-4):243–248. doi: 10.1007/BF00686078. [DOI] [PubMed] [Google Scholar]
  65. Nee L. E., Eldridge R., Sunderland T., Thomas C. B., Katz D., Thompson K. E., Weingartner H., Weiss H., Julian C., Cohen R. Dementia of the Alzheimer type: clinical and family study of 22 twin pairs. Neurology. 1987 Mar;37(3):359–363. doi: 10.1212/wnl.37.3.359. [DOI] [PubMed] [Google Scholar]
  66. Nixon R. A., Clarke J. F., Logvinenko K. B., Tan M. K., Hoult M., Grynspan F. Aluminum inhibits calpain-mediated proteolysis and induces human neurofilament proteins to form protease-resistant high molecular weight complexes. J Neurochem. 1990 Dec;55(6):1950–1959. doi: 10.1111/j.1471-4159.1990.tb05781.x. [DOI] [PubMed] [Google Scholar]
  67. Ohtawa M., Seko M., Takayama F. Effect of aluminum ingestion on lipid peroxidation in rats. Chem Pharm Bull (Tokyo) 1983 Apr;31(4):1415–1418. doi: 10.1248/cpb.31.1415. [DOI] [PubMed] [Google Scholar]
  68. Patocka J. The influence of A1 +++ on cholinesterase and acetylcholinesterase activity. Acta Biol Med Ger. 1971;26(4):845–846. [PubMed] [Google Scholar]
  69. Pendlebury W. W., Perl D. P., Schwentker A., Pingree T. M., Solomon P. R. Aluminum-induced neurofibrillary degeneration disrupts acquisition of the rabbit's classically conditioned nictitating membrane response. Behav Neurosci. 1988 Oct;102(5):615–620. doi: 10.1037//0735-7044.102.5.615. [DOI] [PubMed] [Google Scholar]
  70. Perl D. P., Brody A. R. Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science. 1980 Apr 18;208(4441):297–299. doi: 10.1126/science.7367858. [DOI] [PubMed] [Google Scholar]
  71. Petit T. L., Biederman G. B., McMullen P. A. Neurofibrillary degeneration, dendritic dying back, and learning-memory deficits after aluminum administration: implications for brain aging. Exp Neurol. 1980 Jan;67(1):152–162. doi: 10.1016/0014-4886(80)90166-1. [DOI] [PubMed] [Google Scholar]
  72. Rabe A., Lee M. H., Shek J., Wisniewski H. M. Learning deficit in immature rabbits with aluminum-induced neurofibrillary changes. Exp Neurol. 1982 May;76(2):441–446. doi: 10.1016/0014-4886(82)90220-5. [DOI] [PubMed] [Google Scholar]
  73. Rao K. S. Effects of aluminium salts on synaptosomal enzymes--an in vitro kinetic study. Biochem Int. 1990 Nov;22(4):725–734. [PubMed] [Google Scholar]
  74. Rifat S. L., Eastwood M. R., McLachlan D. R., Corey P. N. Effect of exposure of miners to aluminium powder. Lancet. 1990 Nov 10;336(8724):1162–1165. doi: 10.1016/0140-6736(90)92775-d. [DOI] [PubMed] [Google Scholar]
  75. Sampson M., Clarkson D., Davies D. D. DNA Synthesis in Aluminum-Treated Roots of Barley. Science. 1965 Jun 11;148(3676):1476–1477. doi: 10.1126/science.148.3676.1476. [DOI] [PubMed] [Google Scholar]
  76. Selkoe D. J., Liem R. K., Yen S. H., Shelanski M. L. Biochemical and immunological characterization of neurofilaments in experimental neurofibrillary degeneration induced by aluminum. Brain Res. 1979 Mar 16;163(2):235–252. doi: 10.1016/0006-8993(79)90352-4. [DOI] [PubMed] [Google Scholar]
  77. Shepherd N. A., Crocker P. R., Smith A. P., Levison D. A. Exogenous pigment in Peyer's patches. Hum Pathol. 1987 Jan;18(1):50–54. doi: 10.1016/s0046-8177(87)80193-4. [DOI] [PubMed] [Google Scholar]
  78. Siegel N., Haug A. Aluminum interaction with calmodulin. Evidence for altered structure and function from optical and enzymatic studies. Biochim Biophys Acta. 1983 Apr 14;744(1):36–45. doi: 10.1016/0167-4838(83)90337-0. [DOI] [PubMed] [Google Scholar]
  79. Simpson J., Yates C. M., Whyler D. K., Wilson H., Dewar A. J., Gordon A. Biochemical studies on rabbits with aluminium induced neurofilament accumulations. Neurochem Res. 1985 Feb;10(2):229–238. doi: 10.1007/BF00964569. [DOI] [PubMed] [Google Scholar]
  80. Slater D. N., Underwood J. C., Durrant T. E., Gray T., Hopper I. P. Aluminium hydroxide granulomas: light and electron microscopic studies and X-ray microanalysis. Br J Dermatol. 1982 Jul;107(1):103–108. doi: 10.1111/j.1365-2133.1982.tb00297.x. [DOI] [PubMed] [Google Scholar]
  81. Solomon P. R., Pingree T. M., Baldwin D., Koota D., Perl D. P., Pendlebury W. W. Disrupted retention of the classically conditioned nictitating membrane response in rabbits with aluminum-induced neurofibrillary degeneration. Neurotoxicology. 1988 Summer;9(2):209–221. [PubMed] [Google Scholar]
  82. Sprague S. M., Corwin H. L., Tanner C. M., Wilson R. S., Green B. J., Goetz C. G. Relationship of aluminum to neurocognitive dysfunction in chronic dialysis patients. Arch Intern Med. 1988 Oct;148(10):2169–2172. [PubMed] [Google Scholar]
  83. St George-Hyslop P. H., Haines J. L., Farrer L. A., Polinsky R., Van Broeckhoven C., Goate A., McLachlan D. R., Orr H., Bruni A. C., Sorbi S. Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature. 1990 Sep 13;347(6289):194–197. doi: 10.1038/347194a0. [DOI] [PubMed] [Google Scholar]
  84. St George-Hyslop P. H., Tanzi R. E., Polinsky R. J., Haines J. L., Nee L., Watkins P. C., Myers R. H., Feldman R. G., Pollen D., Drachman D. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science. 1987 Feb 20;235(4791):885–890. doi: 10.1126/science.2880399. [DOI] [PubMed] [Google Scholar]
  85. Sternweis P. C., Gilman A. G. Aluminum: a requirement for activation of the regulatory component of adenylate cyclase by fluoride. Proc Natl Acad Sci U S A. 1982 Aug;79(16):4888–4891. doi: 10.1073/pnas.79.16.4888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Strong M. J., Wolff A. V., Wakayama I., Garruto R. M. Aluminum-induced chronic myelopathy in rabbits. Neurotoxicology. 1991 Spring;12(1):9–21. [PubMed] [Google Scholar]
  87. Sturman J. A., Wisniewski H. M., Shek J. W. High affinity uptake of GABA and glycine by rabbits with aluminum-induced neurofibrillary changes. Neurochem Res. 1983 Sep;8(9):1097–1109. doi: 10.1007/BF00964925. [DOI] [PubMed] [Google Scholar]
  88. Sturr M. G., Marquis R. E. Inhibition of proton-translocating ATPases of Streptococcus mutans and Lactobacillus casei by fluoride and aluminum. Arch Microbiol. 1990;155(1):22–27. doi: 10.1007/BF00291269. [DOI] [PubMed] [Google Scholar]
  89. Takagi A., Sai K., Umemura T., Hasegawa R., Kurokawa Y. Relationship between hepatic peroxisome proliferation and 8-hydroxydeoxyguanosine formation in liver DNA of rats following long-term exposure to three peroxisome proliferators; di(2-ethylhexyl) phthalate, aluminium clofibrate and simfibrate. Cancer Lett. 1990 Aug;53(1):33–38. doi: 10.1016/0304-3835(90)90007-k. [DOI] [PubMed] [Google Scholar]
  90. Trapp G. A. Plasma aluminum is bound to transferrin. Life Sci. 1983 Jul 25;33(4):311–316. doi: 10.1016/s0024-3205(83)80002-2. [DOI] [PubMed] [Google Scholar]
  91. Troncoso J. C., March J. L., Häner M., Aebi U. Effect of aluminum and other multivalent cations on neurofilaments in vitro: an electron microscopic study. J Struct Biol. 1990 Mar;103(1):2–12. doi: 10.1016/1047-8477(90)90080-v. [DOI] [PubMed] [Google Scholar]
  92. Uemura E., Ireland W. P. Synaptic density in chronic animals with experimental neurofibrillary changes. Exp Neurol. 1984 Jul;85(1):1–9. doi: 10.1016/0014-4886(84)90154-7. [DOI] [PubMed] [Google Scholar]
  93. VanBerkum M. F., Wong Y. L., Lewis P. N., Crapper McLachlan D. R. Total and poly(A) RNA yields during an aluminum encephalopathy in rabbit brains. Neurochem Res. 1986 Sep;11(9):1347–1359. doi: 10.1007/BF00966128. [DOI] [PubMed] [Google Scholar]
  94. Walker P. R., LeBlanc J., Sikorska M. Effects of aluminum and other cations on the structure of brain and liver chromatin. Biochemistry. 1989 May 2;28(9):3911–3915. doi: 10.1021/bi00435a043. [DOI] [PubMed] [Google Scholar]
  95. Wenk G. L., Stemmer K. L. The influence of ingested aluminum upon norepinephrine and dopamine levels in the rat brain. Neurotoxicology. 1981 Oct;2(2):347–353. [PubMed] [Google Scholar]
  96. Womack F. C., Colowick S. P. Proton-dependent inhibition of yeast and brain hexokinases by aluminum in ATP preparations. Proc Natl Acad Sci U S A. 1979 Oct;76(10):5080–5084. doi: 10.1073/pnas.76.10.5080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Wong P. C., Lai J. C., Lim L., Davison A. N. Selective inhibition of L-glutamate and gammaaminobutyrate transport in nerve ending particles by aluminium, manganese, and cadmium chloride. J Inorg Biochem. 1981 Jun;14(3):253–260. doi: 10.1016/s0162-0134(00)80005-7. [DOI] [PubMed] [Google Scholar]
  98. Xu Z. X., Fox L., Melethil S., Winberg L., Badr M. Mechanism of aluminum-induced inhibition of hepatic glycolysis: inactivation of phosphofructokinase. J Pharmacol Exp Ther. 1990 Jul;254(1):301–305. [PubMed] [Google Scholar]
  99. Yamamoto H., Saitoh Y., Yasugawa S., Miyamoto E. Dephosphorylation of tau factor by protein phosphatase 2A in synaptosomal cytosol fractions, and inhibition by aluminum. J Neurochem. 1990 Aug;55(2):683–690. doi: 10.1111/j.1471-4159.1990.tb04187.x. [DOI] [PubMed] [Google Scholar]
  100. Yates C. M., Simpson J., Russell D., Gordon A. Cholinergic enzymes in neurofibrillary degeneration produced by aluminium. Brain Res. 1980 Sep 15;197(1):269–274. doi: 10.1016/0006-8993(80)90458-8. [DOI] [PubMed] [Google Scholar]
  101. Yokel R. A. Repeated systemic aluminum exposure effects on classical conditioning of the rabbit. Neurobehav Toxicol Teratol. 1983 Jan-Feb;5(1):41–46. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES